Anil Kapur

Insider Reports History

Entity
Individual
Location
275 Madison Ave, Suite 702, New York, NY
Signature
/s/ Daniel Burbach, as Attorney-in-Fact for Anil Kapur
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Anil Kapur:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Verastem, Inc. Director Common Stock 8.33K $26.3K $3.16 Jun 18, 2024 Direct
GERON CORP EVP, Corp Strategy & CCO Common Stock 0 $0 $4.65 Jun 10, 2024 Direct
GERON CORP EVP, Corp Strategy & CCO Stock Option (right to buy) 328K Jun 10, 2024 Direct
Nurix Therapeutics, Inc. Director Director Stock Option (right to buy) 50K Oct 15, 2024 Direct
Verastem, Inc. Director Stock Option (right to buy) 12.5K Jun 18, 2024 Direct

Insider Reports Filed by Anil Kapur

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NRIX Nurix Therapeutics, Inc. Oct 15, 2024 1 $0 4 Oct 16, 2024 Director
NRIX Nurix Therapeutics, Inc. Oct 15, 2024 0 $0 3 Oct 16, 2024 Director
VSTM Verastem, Inc. Jun 18, 2024 2 $0 4 Jun 20, 2024 Director
GERN GERON CORP Jun 10, 2024 3 -$1.51M 4 Jun 12, 2024 EVP, Corp Strategy & CCO
GERN GERON CORP Jun 6, 2024 1 $0 4 Jun 7, 2024 EVP, Corp Strategy & CCO
GERN GERON CORP Feb 14, 2024 1 $0 4 Feb 16, 2024 EVP, CORP STRATEGY & CCO
GERN GERON CORP Jun 30, 2023 1 $15.4K 4 Jun 30, 2023 EVP, Corp Strategy & CCO
VSTM Verastem, Inc. May 15, 2023 1 $0 4 May 16, 2023 Director
GERN GERON CORP Feb 22, 2023 1 $0 4 Feb 24, 2023 EVP, Corp Strategy & CCO
GERN GERON CORP Dec 30, 2022 1 $6.68K 4 Jan 3, 2023 EVP, Corp Strategy & CCO
VSTM Verastem, Inc. Oct 20, 2022 1 $0 4 Oct 24, 2022 Director
VSTM Verastem, Inc. Oct 20, 2022 0 $0 3 Oct 24, 2022 Director
GERN GERON CORP Jun 30, 2022 1 $14.5K 4 Jul 1, 2022 EVP, Corp Strategy & CCO
GERN GERON CORP Feb 16, 2022 1 $0 4 Feb 18, 2022 EVP, Corp Strategy & CCO